Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous thrombolysis alone. Tirofiban was approved for the treat...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2022-11-01
|
| Seri Bilgileri: | Frontiers in Neuroscience |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fnins.2022.1026127/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|